ArticleslgStudy

chemistry

Nimodipine

Nimodipine is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Nimodipine rather than just read about it. In short: Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker used in preventing vasospasm secondary to subarachnoid hemorrhage (a form of cerebral hemorrhage). It was originally developed within the calcium channel blocker class as it was used for the treatment of high blood pressure, but is not used for this indication.

Nimodipine — main illustration
Nimodipine — illustration

Key takeaways

  • Nimodipine belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Nimodipine to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Nimodipine from memory before moving on to harder problems.

Reference excerpt

Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker used in preventing vasospasm secondary to subarachnoid hemorrhage (a form of cerebral hemorrhage). It was originally developed within the calcium channel blocker class as it was used for the treatment of high blood pressure, but is not used for this indication. It was patented in 1971 and approved for medical use in the United States in 1988. It was approved for medical use in Germany in 1985.

Medical uses Because it has some selectivity for cerebral vasculature, nimodipine's main use is in the prevention of cerebral vasospasm and resultant ischemia, a complication of subarachnoid hemorrhage (a form of cerebral bleed), specifically from ruptured intracranial berry aneurysms irrespective of the patient's post-ictus neurological condition. Its administration begins within 4 days of a subarachnoid hemorrhage and is continued for three weeks. If blood pressure drops by over 5%, dosage is adjusted. There is still controversy regarding the use of intravenous nimodipine on a routine basis. A 2003 trial found nimodipine was inferior to magnesium sulfate in preventing seizures in women with severe preeclampsia. Nimodipine is not regularly used to treat head injury. Several investigations have been performed evaluating its use for traumatic subarachnoid hemorrhage; a systematic review of 4 trials did not suggest any significant benefit to the patients that receive nimodipine therapy. There was one report case of nimodipine being successfully used for treatment of ultradian bipolar cycling after brain injury and, later, amygdalohippocampectomy.

Dosage The regular dosage is 60 mg tablets every four hours. If the patient is unable to take tablets orally, it was previously given via intravenous infusion at a rate of 1–2 mg/hour (lower dosage if the body weight is <70 kg or blood pressure is too low), but since the withdrawal of the IV preparation, administration by nasogastric tube is an alternative.

Contraindications

Side effects The US Food and Drug Administration (FDA) has classified the side effects into groups based on dosages levels at q4h. For the high dosage group (90 mg) less than 1% of the group experienced adverse conditions including itching, gastrointestinal hemorrhage, thrombocytopenia, neurological deterioration, vomiting, diaphoresis, congestive heart failure, hyponatremia, decreasing platelet count, disseminated intravascular coagulation, and deep vein thrombosis.

Pharmacology

Mechanism of action Nimodipine binds specifically to L-type voltage-gated calcium channels. There are numerous theories about its mechanism in preventing vasospasm, but none are conclusive. Nimodipine has additionally been found to act as an antagonist of the mineralocorticoid receptor, or as an antimineralocorticoid.

Pharmacokinetics

Absorption After oral administration, it reaches peak plasma concentrations within one and a half hours. Patients taking enzyme-inducing anticonvulsants have lower plasma concentrations, while patients taking sodium valproate were markedly higher.

Metabolism Nimodipine is metabolized in the first pass metabolism. The dihydropyridine ring of the nimodipine is dehydrogenated in the hepatic cells of the liver, a process governed by cytochrome P450 isoform 3A (CYP3A). This can be completely inhibited however, by troleandomycin (an antibiotic) or ketoconazole (an antifungal drug).

Excretion Studies in non-human mammals using radioactive labeling have found that 40–50% of the dose is excreted via urine. The residue level in the body was never more than 1.5% in monkeys.

Synthesis

The key acetoacetate (2) for the synthesis of nimodipine (5) is obtained by alkylation of sodium acetoacetate with 2-methoxyethyl chloride, Aldol condensation of meta-nitrobenzene (1) and the subsequent reaction of the intermediate with enamine (4) gives nimodipine.

Stereochemistry Nimodipine contains a stereocenter and can exist as either of two enantiomers. The pharmaceutical drug is a racemate, an equal mixture of the (R)- and (S)- forms.

References

Further reading Towart R, Kazda S (November 1979). "The cellular mechanism of action of nimodipine (BAY e 9736), a new calcium antagonist [proceedings]". British Journal of Pharmacology. 67 (3): 409P–410P. doi:10.1111/j.1476-5381.1979.tb08695.x. PMC 2044020. PMID 497542. Deyo RA, Straube KT, Disterhoft JF (February 1989). "Nimodipine facilitates associative learning in aging rabbits". Science. 243 (4892). New York, N.Y.: 809–11. Bibcode:1989Sci...243..809D. doi:10.1126/science.2916127. PMID 2916127. Use as cerebral vasodilator: GB 2018134, "Cerebral therapeutic agent", assigned to Bayer AG ; eidem, US 4406906, Meyer H, Bossert F, Kazda S, Hoffmeister F, Vater W, issued September 27, 1983, assigned to Bayer AG

Illustrations

Nimodipine illustration
Nimodipine: Dihydropyridine calcium channel blocker. Prepn:[15] H. Meyer et al., U.S. patent 3,799,934 (1974 to Bayer).
Dihydropyridine calcium channel blocker. Prepn:[15] H. Meyer et al., U.S. patent 3,799,934 (1974 to Bayer).
Nimodipine illustration
Nimodipine illustration

Worked examples

Example 1 — a first encounter with Nimodipine

Start with the simplest possible case. Write down what Nimodipine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Nimodipine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Nimodipine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Nimodipine

In research
Nimodipine appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Nimodipine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Nimodipine is common in secondary-school and first-year university syllabi. It links to neighbouring topics 3-Nitrophenyl compounds, Antimineralocorticoids, Calcium channel blockers, so understanding it makes those chapters shorter.
In everyday life
Look for Nimodipine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Nimodipine” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Nimodipine in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Nimodipine means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Nimodipine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Nimodipine in simple terms?

Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker used in preventing vasospasm secondary to subarachnoid hemorrhage (a form of cerebral hemorrhage). It was originally developed within the calcium channel blocker class as it was used for the treatment of high b…

Why does Nimodipine matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Nimodipine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Nimodipine.

Tags

  • 3-Nitrophenyl compounds
  • Antimineralocorticoids
  • Calcium channel blockers
  • Carboxylate esters
  • Dihydropyridines
  • Ethers
  • Isopropyl esters

Keep exploring